-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Relay Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q3 2024.
- Relay Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$96.4M, a 31% decline year-over-year.
- Relay Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$380M, a 7.36% decline year-over-year.
- Relay Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$373M, a 24.6% decline from 2022.
- Relay Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$299M, a 17.9% increase from 2021.
- Relay Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$365M, a 554% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)